Current management of Raynaud's syndrome.

Keyphrases

• Raynaud's Phenomenon 100%
• Nifedipine 100%
• Current Management 100%
• Non-healing 66%
• Etiology 33%
• Sympathectomy 33%
• Pain Relief 33%
• Treatment Options 33%
• Antibiotics 33%
• Calcium Channel Blockers 33%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 33%
• Upper Extremity 33%
• GloVe 33%
• Bedtime 33%
• Extended Release 33%
• Intractable Pain 33%
• Ulcer 33%
• Biofeedback 33%
• Pentoxifylline 33%
• Mild Cases 33%
• Digital Ulcers 33%
• Tobacco Cessation 33%
• Nuisance 33%
• Finger Amputation 33%
• Cold Avoidance 33%
• Fingertip Amputation 33%
• Attack Severity 33%
• Attack Frequency 33%
• Silvadene 33%
• Water Washing 33%

Medicine and Dentistry

• Raynaud Phenomenon 100%
• Nifedipine 100%
• Pathophysiology 33%
• Sympathectomy 33%
• Venous Ulcer 33%
• Analgesia 33%
• Upper Limb 33%
• Calcium Channel Blocking Agent 33%
• ACE Inhibitor 33%
• Amputation 33%
• Intractable Pain 33%
• Fingertip 33%
• Biofeedback 33%
• Phenoxybenzamine 33%
• Finger Ulcer 33%
• Sulfadiazine Silver 33%
• Finger Amputation 33%
• Pentoxifylline 33%
• Antibiotics 33%
• Etiology 33%
• Side Effect 33%
• Treatment Option 33%